A single‐center experience with undifferentiated embryonal sarcoma of the liver | Zendy

Mathias Melissa D. | Zendy; Ambati Srikanth R. | Zendy; Chou Alexander J. | Zendy; Slotkin Emily K. | Zendy; Wexler Leonard H. | Zendy; Meyers Paul A. | Zendy; Magnan Heather | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

A single‐center experience with undifferentiated embryonal sarcoma of the liver

Author(s) -

Mathias Melissa D.,

Ambati Srikanth R.,

Chou Alexander J.,

Slotkin Emily K.,

Wexler Leonard H.,

Meyers Paul A.,

Magnan Heather

Publication year - 2016

Publication title -

pediatric blood and cancer

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.116

H-Index - 105

eISSN - 1545-5017

pISSN - 1545-5009

DOI - 10.1002/pbc.26154

Subject(s) - medicine , single center , embryonal rhabdomyosarcoma , center (category theory) , sarcoma , oncology , pathology , rhabdomyosarcoma , chemistry , crystallography

Undifferentiated embryonal sarcoma of the liver (UESL) is a rare aggressive mesenchymal pediatric tumor. Previously, reported outcomes have been very poor. Here, we report a single‐center experience of five patients with UESL treated with upfront gross total resection and adjuvant chemotherapy. We have a median follow‐up of 8 years with a range from 5 to 19 years with 100% event‐free survival.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research